AzTrials
AzTrials

Immediate Dental Implant PlacementNCT07303374

Flapless Immediate Implant Placement With Socket Shield Technique Versus Connective Tissue Graft in Anterior Maxilla

A study testing IIP+Socket Shield and IIP+CTG in people with Immediate Dental Implant Placement and Connective Tissue Graft, run by International Dental Contiuing Education at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The present study aims to compare the dimensional stability of the supra-implant complex following flapless immediate implant placement using two socket management approaches: the connective tissue graft and the socket shield technique. Read more about this study

Who is it for?
Ages 21 to 50 yearsHealthy volunteers can take part
What is being tested?
IIP+Socket Shield and IIP+CTG
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
1 siteEgypt
Study dates
Feb 2026to May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Initial intact thick gingival biotype
  • 2 mm band of keratinized tissue,
  • Thin intact labial bone plate (< 1mm)
  • Good apical bone for primary stability
  • Patients who had provided an informed consent.

Who cannot join

  • Immediate implants with bone grafts or guided bone regeneration procedures
  • Uncontrolled diabetes mellitus
  • Patients taking IV bisphosphonates for treatment of osteoporosis
  • Patients with active infection related at the site of implant
  • Patients with untreated active periodontal diseases.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Nourhan Gamal AbdelAziz, Masters contact

+201064249441

Nourhannegamal259@gmail.com

Egypt1 site
  • International Dental contiuing education

    Cairo

    Nourhan Gamal Dr. Nourhan Gamal, Masters, +201064249442, Nourhannegamal259@gmail.com

Other trials in Egypt

About this study

Official title: Supra-Implant Complex Stability Following Flapless Immediate Implant Placement With Socket Shield Technique Versus Connective Tissue Graft in Anterior Maxilla 1-Year Randomized Clinical Trial

The present study aims to compare the dimensional stability of the supra-implant complex following flapless immediate implant placement using two socket management approaches: the connective tissue graft and the socket shield technique. Three-dimensional volumetric analysis and cone-beam computed tomography (CBCT) will be employed to assess and quantify changes in soft and hard tissue thickness and height surrounding the implant site.

Read the detailed description

The current study will include 28 non-restorable single maxillary anterior teeth indicated for extraction. Patients will be randomly allocated into two equal groups. The test group will undergo immediate implant placement combined with the socket shield technique and a customized healing abutment, whereas the control group will receive immediate implant placement with connective tissue grafting and a customized healing abutment. A pilot surgical guide will be used for both groups. The primary outcome measure will be labio-palatal ridge dimension changes changes. Secondary outcome measures included labial soft-tissue volumetric changes, bone formation labial to the implant, vertical bone level changes and pink esthetic score. All outcomes will be evaluated after a 12-month follow-up period.

Being tested
IIP+Socket Shield, IIP+CTG
Keywords
Socket Shield, Connective tissue graft

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IIP+Socket ShieldProcedure or surgery

    The socket shield technique, which preserves a labial root fragment to maintain periodontal ligament support.

  • IIP+CTGProcedure or surgery

    connective tissue grafting which increases soft-tissue volume

Study groups in NCT07303374
Study groupRoleWhat they receive
IIP+ Socket sheildExperimentalThe socket shield technique, which preserves a labial root fragment to maintain periodontal ligament support
Receives: Procedure: IIP+Socket Shield
IIP+CTGActive comparatorconnective tissue grafting which increases soft-tissue volume
Receives: Procedure: IIP+CTG

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Soft tissue Volume gain/loss

    The volumetric analysis in this clinical trial will be performed to obtain profilometric measurements. intraoral scans will be taken at baseline, 6- and 12-month post-operative for each patient. The best-fit algorithm will be used to superimpose digital surface models, when comparing each area of interest (AOI) throughout out the follow up period. Unchanged neighboring teeth surfaces will be used as a reference for proper superimposition. In each patient, the AOI will be kept constant for all pairwise comparisons. The volumetric analysis software will calculate the overall buccal soft tissue volume loss/gain (mm3) within the AOI for each patient.

    Measured: one year

Secondary outcomes (1)
  1. Mid-facial gingival margin level

    linear change of the Mid-facial gingival margin pre- and after one year

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2025
  2. Study startFeb 2026 (estimated)
  3. Primary completionApr 2027 (estimated)
  4. Study completionMay 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patients will be randomly allocated into two equal groups. The test group will undergo immediate implant placement combined with the socket shield technique and a customized healing abutment, whereas the control group will receive immediate implant placement with connective tissue grafting and a customized healing abutment. A pilot surgical guide will be used for both groups. The primary outcome measure will be labio-palatal ridge dimension changes changes. Secondary outcome measures included labial soft-tissue volumetric changes, bone formation labial to the implant, vertical bone level changes and pink esthetic score. All outcomes will be evaluated after a 12-month follow-up period.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
28 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07303374
Sponsor's protocol ID
IDCE-38122025
Status last verified
Dec 2025
First submitted
8 Dec 2025
Last updated
24 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing IIP+Socket Shield and IIP+CTG in people with Immediate Dental Implant Placement and Connective Tissue Graft, run by International Dental Contiuing Education at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nourhan Gamal AbdelAziz, Masters (+201064249441, Nourhannegamal259@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Soft tissue Volume gain/loss (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in